Oscar Bladh

Danderyd, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Vaccination-first immune priming shapes a sustained mRNA vaccine-induced IgG4 class switch that associates with SARS-CoV-2 breakthrough infection risk.

Vaccination-first immune priming shapes a sustained mRNA vaccine-induced IgG4 class switch that associates with SARS-CoV-2 breakthrough infection risk.

Journal: Scientific reports

Published: May 29, 2026

Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults.

Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults.

Journal: Vaccine

Published: December 28, 2025

The role of mucosal IgA in protection against influenza A H1N1 virus infection in a real-world setting.

The role of mucosal IgA in protection against influenza A H1N1 virus infection in a real-world setting.

Journal: EBioMedicine

Published: November 21, 2025

Comparing methods collecting mucosal secretions and detecting SARS-CoV-2 spike IgA in three laboratories across three countries.

Comparing methods collecting mucosal secretions and detecting SARS-CoV-2 spike IgA in three laboratories across three countries.

Journal: Vaccine

Published: June 11, 2025

Risk factors for further recurrences of Clostridioides difficile infection at the first and second recurrence: a retrospective cohort.

Risk factors for further recurrences of Clostridioides difficile infection at the first and second recurrence: a retrospective cohort.

Journal: BMC infectious diseases

Published: June 03, 2025

Impact of systemic SARS-CoV-2 vaccination on mucosal IgA responses to subsequent breakthrough infection.

Impact of systemic SARS-CoV-2 vaccination on mucosal IgA responses to subsequent breakthrough infection.

Journal: EBioMedicine

Published: August 23, 2024

Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023.

Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023.

Journal: The Lancet regional health. Europe

Published: January 04, 2024

Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.

Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.

Journal: Frontiers in immunology

Published: November 29, 2023

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden.

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden.

Journal: The Lancet. Infectious diseases

Published: November 24, 2023

Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.

Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.

Journal: The New England journal of medicine

Published: October 27, 2023

Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden.

Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden.

Journal: The Lancet regional health. Europe

Published: July 21, 2023

Mucosal IgA protects against BQ.1 and BQ.1.1 infection.

Mucosal IgA protects against BQ.1 and BQ.1.1 infection.

Journal: The Lancet. Infectious diseases

Published: June 08, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026